Select Page

Applying a pharma mindset to cannabis product development

Driven by emerging clinical evidence and increasingly favourable regulatory conditions, companies are racing to develop cannabis-based pharmaceuticals for diverse indications. As competition intensifies, Shift Health believes three key trends will continue to shape the medical cannabis industry, namely:

  1. The convergence of novel plant, extraction and delivery technologies
  2. Growth in pharmaceutical-grade testing of cannabis/cannabinoid receptor-modulating products
  3. Nascent, if maturing, market perceptions of the health benefits of cannabis

In this paper, we explore these trends further and consider their implications for bringing novel cannabis-based drugs to market.

Contact us for more information about applying a pharma mindset to cannabis-based development and Shift Health’s track record in this arena.